Prestalia
Product Images NDC 72931-010

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prestalia (NDC 72931-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Adhera Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1.a (Adhera 01)

A line graph comparing the percentage of patients with systolic blood pressure (SBP) below 140 mmHg across different baseline SBP values (140 to 180 mmHg). It features three labeled treatment lines: Prestalia 14/10 mg, Amlodipine 10 mg, and Perindopril erbumine 16 mg, each showing a decline in percentage as baseline SBP increases.*

FDA Label Image

Figure 1.b (Adhera 02)

Line graph comparing the percentage of systolic blood pressure (SBP) below 130 mmHg on the y-axis against baseline SBP (mmHg) on the x-axis for three treatments: Prestalia 14/10 mg, Amlodipine 10 mg, and Perindopril erbumine 16 mg. The graph shows decreasing percentages with higher baseline SBP for each treatment, with Prestalia 14/10 mg consistently higher than the other two.*

FDA Label Image

Figure 1.c (Adhera 03)

A line graph depicting the relationship between baseline diastolic blood pressure (DBP) in mmHg (x-axis) and the percentage of patients with DBP less than 90 mmHg (y-axis). The graph includes three labeled curves for Prestalia 14/10 mg, Amlodipine 10 mg, and Perindopril erbumine 16 mg, showing comparative efficacy across baseline DBP values.*

FDA Label Image

Figure 1.d (Adhera 04)

A line chart comparing the percentage of patients achieving diastolic blood pressure (DBP) under 80 mmHg versus baseline DBP (mmHg). The graph includes three lines labeled Prestalia 14/10 mg, Amlodipine 10 mg, and Perindopril erbumine 16 mg, showing their respective reductions in DBP across a baseline range of 90 to 115 mmHg.*

FDA Label Image

Chemical Structure (Adhera 05)

Chemical structure of the active ingredients in Prestalia by Adhera Therapeutics, Inc., showing detailed molecular formulas for two compounds depicted with carbon, oxygen, nitrogen, and hydrogen atoms in standard notation.*

FDA Label Image

Chemical Structure (Adhera 06)

Chemical structure diagram showing the molecular structures of the active ingredients in Prestalia, including a chlorophenyl-substituted quinoline derivative and a benzenesulfonic acid moiety.*

FDA Label Image

Principal Display Panel (3.5 mg/2.5 mg Tablet Bottle Label)

Prestalia 3.5 mg/2.5 mg tablets packaging label showing the active ingredients perindopril arginine 3.5 mg and amlodipine besylate 2.5 mg. The label indicates a 90-tablet count and includes the NDC code 72931-010-02. It is manufactured by Patheon Pharmaceuticals, Inc., and marketed by Adhera Therapeutics, Inc. The label includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (7 mg/5 mg Tablet Bottle Label)

Label for Prestalia tablets containing 7 mg of perindopril arginine and 5 mg of amlodipine. The package includes 90 tablets. Manufactured by Patheon Pharmaceuticals Inc. and marketed by Adhera Therapeutics, Inc. The label features dosage details, storage instructions, and safety warnings.*

FDA Label Image

Principal Display Panel (14 mg/10 mg Tablet Bottle Label)

Label for Prestalia tablets containing 14 mg perindopril arginine and 10 mg amlodipine besylate. The label indicates 90 tablets per package, manufactured by Patheon Pharmaceuticals, Inc., and marketed by Adhera Therapeutics, Inc. It includes storage instructions and cautions to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.